Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes

Some physicians still shy away from using thiazides first-line for hypertension due to concerns about inducing diabetes.

It's true that thiazides increase the risk of hyperglycemia and new-onset diabetes.

But a new analysis of the large ALLHAT hypertension trial shows that this does NOT translate into a higher risk of CV events or death.